Matthew Ho Zhi Guang
Overview
Explore the profile of Matthew Ho Zhi Guang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guang M, Kavanagh E, Dunne L, Dowling P, Zhang L, Lindsay S, et al.
Cancers (Basel)
. 2019 Jan;
11(1).
PMID: 30634515
Despite significant advances in cancer diagnostics and therapeutics the majority of cancer unfortunately remains incurable, which has led to continued research to better understand its exceptionally diverse biology. As a...
2.
Parsons M, McParland D, Szklanna P, Guang M, OConnell K, OConnor H, et al.
Front Cardiovasc Med
. 2017 Nov;
4:68.
PMID: 29164135
Nanoparticle tracking analysis (NTA) can be used to quantitate extracellular vesicles (EVs) in biological samples and is widely considered a useful diagnostic tool to detect disease. However, accurately profiling EVs...
3.
Guang M, McCann A, Bianchi G, Zhang L, Dowling P, Bazou D, et al.
Leuk Lymphoma
. 2017 Jun;
59(3):542-561.
PMID: 28610537
Multiple myeloma (MM) is among the most compelling examples of cancer in which research has markedly improved the length and quality of lives of those afflicted. Research efforts have led...
4.
Zhang Y, Guang M, Zhuo H, Min X, Yao Q, Gu A, et al.
Acta Haematol
. 2017 Feb;
137(2):106-112.
PMID: 28208145
Mantle cell lymphoma (MCL) remains incurable and new treatments are needed, especially in the relapsed/refractory setting. We therefore investigated the effects of carfilzomib, a novel, long-acting, second-generation proteasome inhibitor, in...